Literature DB >> 30104121

Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.

Galina F Makhaeva1, Natalia P Boltneva1, Sofya V Lushchekina2, Elena V Rudakova1, Olga G Serebryakova1, Larisa N Kulikova3, Andrei A Beloglazkin3, Roman S Borisov3, Rudy J Richardson4.   

Abstract

We investigated the biological activity of a series of substituted chromeno[3,2-c]pyridines, including compounds previously synthesized by our group and novel compounds whose syntheses are reported here. Tandem transformation of their tetrahydropyridine ring under the action of activated alkynes yielding 2-vinylsubstituted chromones was used to prepare nitrogen-containing derivatives of a biologically active chromone system. The inhibitory activity of these chromone derivatives against acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and carboxylesterase (CaE) was investigated using the methods of enzyme kinetics and molecular docking. Antioxidant (antiradical) activity of the compounds was assessed in the ABTS assay. The results demonstrated that a subset of the studied chromone derivatives selectively inhibit BChE but do not exhibit antiradical activity. In addition, the results of molecular docking effectively explained the observed features in the efficacy, selectivity, and mechanism of BChE inhibition by the chromone derivatives.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2-vinyl-substituted chromones; Alzheimer’s disease; Butyrylcholinesterase inhibitors; Chromenopyridine; Esterase profile; Molecular docking; Tandem transformation, Activated alkynes

Mesh:

Substances:

Year:  2018        PMID: 30104121     DOI: 10.1016/j.bmc.2018.08.010

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

Review 1.  Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.

Authors:  Hari Madhav; Ehtesham Jameel; Mohammad Rehan; Nasimul Hoda
Journal:  RSC Med Chem       Date:  2022-01-31

2.  Current Strategies in Development of New Chromone Derivatives with Diversified Pharmacological Activities: A Review.

Authors:  Noor Ul Amin Mohsin; Muhammad Irfan; Shams Ul Hassan; Usman Saleem
Journal:  Pharm Chem J       Date:  2020-06-15       Impact factor: 0.837

Review 3.  From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease.

Authors:  Jazmín Alarcón-Espósito; Michael Mallea; Julio Rodríguez-Lavado
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.